Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Private equity poised to drive traditional TV consolidation from 2026, TD Cowen predicts
Private equity poised to drive traditional TV consolidation from 2026, TD Cowen predicts Private equity firms are likely to emerge as the primary consolidators of traditional TV networks starting in 2026, as regulatory challenges continue to stall large-scale mergers...
Bain Capital leads $2bn investment talks for insurance giant Acrisure
Bain Capital leads $2bn investment talks for insurance giant Acrisure Bain Capital’s special situations unit is in advanced talks to lead a $2bn preferred equity investment in Acrisure, the fast-growing US-based insurance and fintech platform, according to sources...
Avallon MBO launches €260m fund to back management buyouts across Central Europe
Avallon MBO launches €260m fund to back management buyouts across Central Europe Avallon MBO has launched its fourth fund, Avallon MBO Fund IV, with a fundraising target of between €220m and €260m as it looks to build on its strong track record in the management...